ANGPTL8 and metabolic dysfunction-associated steatotic liver disease: If this holds true, a dysmetabolic progression occurring during adulthood could disentangle ANGPTL8 function as an adipokine, which could then act to signal comorbidities relating to insulin resistance and NAFLD [18].